Endoscopic Ultrasonography-Guided Ethanol Ablation for Small Pancreatic Neuroendocrine Tumors: Results of a Pilot Study
1
조회
0
다운로드
13
인용
0
참고문헌
키워드
초록
Background/Aims: Endoscopic ultrasonography (EUS)-guided ethanol ablation is gaining popularity for the treatment of focal pancreatic lesions. The aim of this study was to evaluate the safety, feasibility, and treatment response after EUS-guided ethanol injection for small pancreatic neuroendocrine tumors (p-NETs). Methods: This was a retrospective analysis of a prospectively collected database including 11 consecutive patients with p-NETs who underwent EUS-guided ethanol injection. Results: EUS-guided ethanol injection was successfully performed in 11 patients with 14 tumors. The final diagnosis was based on histology and clinical signs as follows: 10 non-functioning neuroendocrine tumors and four insulinomas. During follow-up (median, 370 days; range, 152 to 730 days), 10 patients underwent clinical follow-up after treatment, and one patient was excluded because of loss to follow-up. A single treatment session with an injection of 0.5 to 3.8 mL of ethanol resulted in complete responses (CRs) at the 3-month radiologic imaging for seven of 13 tumors (response rate, 53.8%). Multiple treatment sessions performed in three tumors with residual viable enhancing tissue increased the number of tumors with CRs to eight of 13 (response rate, 61.5%). Mild pancreatitis occurred in three of 11 patients. Conclusions: EUS-guided ethanol injection appears to be a safe, feasible, and potentially effective method for treating small p-NETs in patients who are poor surgical candidates.
Abstract
Background/Aims: Endoscopic ultrasonography (EUS)-guided ethanol ablation is gaining popularity for the treatment of focal pancreatic lesions. The aim of this study was to evaluate the safety, feasibility, and treatment response after EUS-guided ethanol injection for small pancreatic neuroendocrine tumors (p-NETs). Methods: This was a retrospective analysis of a prospectively collected database including 11 consecutive patients with p-NETs who underwent EUS-guided ethanol injection. Results: EUS-guided ethanol injection was successfully performed in 11 patients with 14 tumors. The final diagnosis was based on histology and clinical signs as follows: 10 non-functioning neuroendocrine tumors and four insulinomas. During follow-up (median, 370 days; range, 152 to 730 days), 10 patients underwent clinical follow-up after treatment, and one patient was excluded because of loss to follow-up. A single treatment session with an injection of 0.5 to 3.8 mL of ethanol resulted in complete responses (CRs) at the 3-month radiologic imaging for seven of 13 tumors (response rate, 53.8%). Multiple treatment sessions performed in three tumors with residual viable enhancing tissue increased the number of tumors with CRs to eight of 13 (response rate, 61.5%). Mild pancreatitis occurred in three of 11 patients. Conclusions: EUS-guided ethanol injection appears to be a safe, feasible, and potentially effective method for treating small p-NETs in patients who are poor surgical candidates.
참고문헌 (19)
- O’Grady HL, "Pancreatic neuroendocrine tumours", Eur J Surg Oncol, 34, pp.324~332 (2008)
- Modlin IM, "Gastroenteropancreatic neuroendocrine tumours", Lancet Oncol, 9, pp.61~72 (2008)
- Cherenfant J, "Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors", Surgery, 154, pp.785~791 (2013)
- Oberg K, "Endocrine tumours of the pancreas", Best Pract Res Clin Gastroenterol, 19, pp.753~781 (2005)
- Falconi M, "Well-differentiated pancreatic nonfunctioning tumors", carcinoma, 2006, pp.84, 196~211
- Bettini R, "Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor", Surgery, 150, pp.75~82 (2011)
- Oh HC, "Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts", Gastroenterology, 140, pp.172~179 (2011)
- Larssen TB, "Single-session alcohol sclerotherapy in symptomatic benign hepatic cysts performed with a time of exposure to alcohol of 10 min: initial results", Eur Radiol, 13, pp.2627~2632 (2003)
- Aslanian H, "EUS-guided ethanol injection of normal porcine pancreas: a pilot study", Gastrointest Endosc, 62, pp.723~727 (2005)
- Deprez PH, "Successful endoscopic ultrasound-guided ethanol ablation of a sporadic insulinoma", Acta Gastroenterol Belg, 71, pp.333~337 (2008)
- Jürgensen C, "EUS-guided alcohol ablation of an insulinoma", Gastrointest Endosc, 63, pp.1059~1062 (2006)
- Levy MJ, "US-guided ethanol ablation of insulinomas: a new treatment option", Gastrointest Endosc, 75, pp.200~206 (2012)
- Vleggaar FP, "Endoscopic ultrasound-guided ethanol ablation of a symptomatic sporadic insulinoma", Endoscopy, 43(2), pp.E328~E329 (2011)
- Zhang WY, "Endoscopic ultrasound-guided ethanol ablation therapy for tumors", World J Gastroenterol, 19, pp.3397~3403 (2013)
- Gelczer RK, "Complications of percutaneous ethanol ablation", J Ultrasound Med, 17, pp.531~533 (1998)
- Matthes K, "Concentration-dependent ablation of pancreatic tissue by EUS-guided ethanol injection", Gastrointest Endosc, 65, pp.272~277 (2007)
- Lencioni R, "Single-session percutaneous ethanol ablation of early-stage hepatocellular carcinoma with a multipronged injection needle: results of a pilot clinical study", J Vasc Interv Radiol, 21, pp.1533~1538 (2010)
- Kitano M, "Endoscopic ultrasound: contrast enhancement", Gastrointest Endosc Clin N Am, 22, pp.349~358 (2012)
- Giday SA, "The utility of contrast-enhanced endoscopic ultrasound in monitoring ethanol-induced pancreatic tissue ablation: a pilot study in a porcine model", Endoscopy, 39, pp.525~529 (2007)